GlassScriptPhysician profile
Aaron B House
NPI 1215161328
$78,978.98
in general payments reported to CMS, 2019-2025
32 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $93.92 · 2021: $29K · 2022: $9,729 · 2023: $17K · 2024: $5,707 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $2,135 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Food and Beverage | $2,135.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $130.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $76,787.69 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $606.86 | 2019-2025 | Phasix Mesh, Arista |
| Becton, Dickinson and Company | $343.79 | 2024 | Phasix Mesh |
| Innovation Technologies INC | $140.84 | 2025 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $121.93 | 2019-2024 | Tagrisso |
| Janssen Biotech, INC. | $102.18 | 2024-2025 | Rybrevant, Tecvayli |
| Regeneron Healthcare Solutions, INC. | $86.96 | 2024 | Libtayo |
| Ethicon US, LLC | $70.54 | 2021-2023 | Surgicel Nu-Knit, Vistaseal, Echelon Flex |
| Molli Surgical (US) INC | $67.90 | 2023 | |
| Merck Sharp & Dohme LLC | $64.96 | 2023-2025 | Keytruda |
| Abbott Laboratories | $64.10 | 2019 | |
| Abbvie INC. | $59.46 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.97 | 2022-2023 | Gattex |
| Kerecis Limited | $40.88 | 2022 | |
| Adc Therapeutics America, INC. | $36.96 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $33.62 | 2023 | Bavencio |
| Pacira Pharmaceuticals Incorporated | $32.23 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $28.59 | 2025 | |
| Jazz Pharmaceuticals INC. | $27.38 | 2025 | |
| Polynovo North America LLC | $22.10 | 2025 | Novosorb Btm |
| Cumberland Pharmaceuticals, INC. | $20.71 | 2023 | Sancuso |
| Aveo Pharmaceuticals, INC. | $18.24 | 2023 | Fotivda |
| Vertex Pharmaceuticals Incorporated | $17.83 | 2025 | |
| Novo Nordisk INC | $16.88 | 2022 | |
| Leica Microsystems INC. | $16.34 | 2022 | |
| Morphosys, US INC. | $15.76 | 2023 | Monjuvi |
| Stryker Corporation | $15.70 | 2025 | Molli |
| Eisai INC. | $15.16 | 2025 | |
| Tela Bio, INC. | $14.72 | 2021 | |
| Merit Medical Systems INC | $13.81 | 2023 | Savi Scout |
| Gilead Sciences, INC. | $12.93 | 2022 | |
| Hologic INC | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.